Skip to content

Trademark Protection on Amazon: Why Pharmaceutical and Healthcare Brands Need to Act Now

Brand management for healthcare companies on Amazon is shifting from a passive distribution choice to a critical compliance mandate where active governance defines protection. This is illustrated by the severe risks of cross-border content overwrites and pharmacovigilance liabilities that require immediate enrollment in the Amazon Brand Registry to safeguard patient safety and data accuracy.
Grafik zum Thema Markenschutz auf Amazon

Today, Amazon is no longer just one of the largest product search engines, but also a major AI and comparison platform – especially for prescription drugs, dietary supplements, medical devices, and healthcare products. But while many pharmaceutical and healthcare companies carefully plan their sales strategies, one critical area often remains unchecked: What happens to their brand on Amazon marketplaces? Active brand protection on Amazon is not optional for regulated industries – it is essential!

The invisible problem: Lack of control over one's own brand

Many brands underestimate just how widely their products are already available on Amazon – whether they know it or not. Third-party sellers, parallel importers, and distributors list products on their own, often with outdated, incorrect, or even misleading product information. The result:

  • Incorrect dosage information or indications on product pages
  • Outdated packaging images that no longer comply with the current approval
  • Incorrect or missing required information (e.g., package insert)
  • Does not align with current brand messaging

For consumers, a product page on Amazon is equivalent to the brand’s official presence. Inconsistent or inaccurate information not only damages the brand’s image; in the worst-case scenario, it can jeopardize patient safety.

Amazon's Global Content Mechanism: An Underestimated Compliance Risk

What many brands don’t realize is that Amazon operates as a unified platform infrastructure across Europe. This means that product content – PDPs (Product Detail Pages), images, bullet points, and descriptions – can be shared and overwritten across countries. Brands that don’t actively maintain and monitor their content effectively relinquish that control.
A real-world example: A distributor maintains product data for amazon.it. The Italian-language content stored there – including country-specific indications and dosage information – suddenly appears on amazon.de or amazon.fr as well, because Amazon automatically pulls missing content from other marketplaces. The result: On the German marketplace, product pages are displayed in the wrong language, with mandatory information that does not apply to the German approval text.
This behavior is not a system error, but rather Amazon’s mechanism for keeping product pages as complete as possible. The algorithm actively searches for available content when the marketplace responsible for the product does not provide complete data. For regulated products, this poses a significant compliance risk:

  • Country-specific approval texts appear on the wrong marketplace
  • Grammatical errors or incorrect mandatory information are considered violations by government agencies – regardless of who originally entered the content
  • The brand owner bears regulatory responsibility, even if a distributor or another marketplace was the source

The bottom line: Protecting your brand on Amazon means more than just monitoring your own marketplaces. It means keeping an eye on all European Amazon marketplaces, even those where you don’t actively sell.

Trademark protection is a compliance issue – not just a nice-to-have

In the pharmaceutical and healthcare sectors, brand management is inextricably linked to regulatory requirements. Companies that do not actively manage their brands risk compliance violations, even if they do not sell on Amazon themselves.

Pharmacovigilance: Legal Framework and Digital Responsibility

EU pharmacovigilance legislation (Directive 2010/84/EU, GVP modules) requires marketing authorization holders to continuously monitor their products – including in the digital space. Specifically, this means:

  • Adverse events (reports of side effects) may be received through Amazon reviews and must be identified and reported.
  • Product information on third-party platforms must reflect the current approval status.
  • Manufacturers are also liable if third parties disseminate false claims, provided that no active corrective measures have been taken.

Structured Amazon monitoring is therefore not merely a marketing tool, but rather a component of the pharmacovigilance system and, as such, should be integrated into the company’s internal processes.

Trademark Infringements on Amazon: The Most Common Scenarios

For many pharmaceutical brands, the reality on Amazon is shocking once they conduct a systematic analysis for the first time. In practice, these violations are the most common:

  • Logo removal and image manipulation: Third-party providers paint over or remove brand logos from product images in order to place their own brands or to feign originality.
  • Incorrect manufacturer and brand information: Products are listed under a different brand name or with altered manufacturer information.
  • Product Product Hijacking: Third-party sellers hijack existing ASIN listings, list their own (often inferior) products under them, and capitalize on the original brand’s ranking and reviews.
  • Reputational damage due to quality issues: If a counterfeit or improperly stored product is sold under the original ASIN and causes adverse effects, the brand bears the reputational damage.

What should you do if you don't sell on Amazon yourself?

“We don’t sell on Amazon” or “We give our Amazon partner free rein” – these statements are not protective measures and cannot prevent significant damage. They simply mean that brand owners have no direct control over how their brand is presented and used on the marketplaces. Nevertheless, the products are there and are being sold.

Due to their distribution strategies or regulatory requirements, many brands are unable to actively sell on Amazon themselves. Nevertheless, there are various options for actively protecting the brand, which can also have a positive impact on brand visibility and sales.

Four steps you can take even without an Amazon account:

  1. Distributor Briefing: Business partners and distributors must be provided with clear content guidelines for Amazon. Images, product descriptions, claims, and compliance requirements must be documented in writing, regularly updated, and reviewed.
  2. Brand Governance Strategy: An internal policy defines who is authorized to list which products on which marketplaces and under what conditions. It includes clear escalation procedures in the event of violations.
  3. Amazon Brand Registry: Even if you don’t sell your own products, you can and should register your brand with the Amazon Brand Registry. This provides the rights holder with tools to report and remove unauthorized listings. Partners and distributors can be registered here and granted permission to use the trademarks.
  4. Internal training: Regulatory Affairs, Marketing, Sales, and Legal must work together to understand the risks posed by uncontrolled marketplace listings. This is the only way to develop a coherent protection strategy.

Proper trademark protection pays off – even in sales

Trademark protection on Amazon is not purely a defensive measure. Brands that actively manage their presence benefit in several ways:

  • Better content, better conversion: A+ Content, Brand Stores, and consistent product descriptions have been shown to increase conversion rates, provided the brand has control over its listings.
  • Greater visibility: Amazon’s algorithm prioritizes content that is complete, accurate, and protected by trademark law. Trademark protection and SEO performance are directly linked.
  • Brand Awareness and Storytelling: The Brand Store offers a dedicated brand platform within Amazon. Here, healthcare brands can build trust, showcase their expertise, and tell their brand story. This is particularly important in an industry where trust is a key factor in purchasing decisions.
  • Long-term revenue stability: Product hijacking and counterfeits directly impact revenue and reputation. By protecting your ASIN infrastructure, you safeguard your revenue and brand image.

Conclusion: Trademark protection on Amazon is a top priority

For pharmaceutical and healthcare brands, Amazon is not a neutral channel that can be ignored. It presents a regulatory, reputational, and commercial challenge all at once. Companies that fail to invest in systematic Amazon brand monitoring and structured brand governance today risk compliance violations, reputational damage, and lost revenue tomorrow.

The first step is simple: conduct a thorough assessment. On which marketplaces are my products listed? Which sellers are carrying my brand? Does the content comply with approval requirements and brand guidelines? If you can answer these questions, you’re well on your way. If you can’t, you have a problem and should address it before it’s too late.

Would you like to know how your brand is positioned on Amazon?

Contact us – we help pharmaceutical and healthcare brands develop a customized Amazon brand governance strategy.

Get in Touch 

Do you have questions or would like to exchange ideas? Whether it’s general topics about Amazon or specific project inquiries — our team is here for you. Let’s achieve your goals together!

Kontaktaufnahme-Bereich auf der Website